Read + Share
Friedberg JW, Bordoni R, Patel-Donnelly D, Larson T, et al. Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for
older patients ineligible for chemotherapy. Blood 2024;143:786-795.
PMID: 37946283
|
 |
|
Friedberg JW, Bordoni R, Patel-Donnelly D, Larson T, et al. Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for
older patients ineligible for chemotherapy. Blood 2024;143:786-795.
PMID: 37946283
|
|
|
|